Exosome Therapeutics Market

Exosome Therapeutics Market Size by Therapy Type (Allogenic and Autologous), Application (Cancer Treatment, Cardiovascular Diseases, Infectious Diseases and Neurological Disorders), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2025 to 2034

Base Year: 2024 Historical Data: 2021-23
  • Report ID: TBI-14790
  • Published Date: Aug, 2025
  • Pages: 238
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

Market Introduction

The global Exosome Therapeutics market was valued at USD 88.10 Million in 2024 and grew at a CAGR of 38.58% from 2025 to 2034. The market is expected to reach USD 2,301.47 Million by 2034. This market is observing significant growth. Exosomes are extracellular vesicles that are released by cells. It is gaining attention as a potential therapeutic agent due to its unique properties and ability to deliver therapeutic cargo to target cells. Exosomes are showing promise for various therapeutic applications, including oncology, regenerative medicine, cardiovascular disease, neurology, and immune disorders. Many leading researchers are exploring the possibilities of delivering drugs, proteins, nucleic acids, and other substances.  Exosomes offer several advantages as therapeutic agents, including natural targeting abilities, the ability to cross biological barriers, low immunogenicity, and inherent stability. Moreover, exosomes released from various cell sources can be tailored for specific therapeutic applications.

Exosomes are extracellular vesicles (EVs) of endosomal origin, which have a size range between 30 and 150 nanometers. A broad range of cells secretes it as virtually all living cells use exosome-mediated communication. Exosomes consist of cell-specific cargos of lipids, proteins and nucleic acids, which are accordingly taken up by the receiver cells. In the past few years, it has been observed that many investors have poured millions of capital into exosome-based therapeutics. More than 100 trials involving exosomes have been conducted, and some of them are assessing therapeutics tailored to specific conditions, such as cancer. Exosomes offer several advantages as therapeutic agents, as they possess targeting abilities naturally and can easily cross biological barriers, exhibit low immunogenicity, and provide inherent stability. Moreover, exosomes are secreted from different cell sources that can be designed for particular therapeutic applications.

It has been observed that both leading biopharmaceutical organisations and academic institutions are heavily involved in R&D efforts related to exosome therapeutics. Additionally, they are focusing on optimising production approaches and developing a standardised isolation method. They are also working on enhancing the cargo-loading capacity of exosomes. Several clinical trials are currently underway to assess the safety and efficacy of exosome-based therapies. These trials aim to harness the potential of exosomes in the treatment of various diseases and conditions, providing valuable data for future regulatory approvals and commercialisation. The exosome therapeutics sector is witnessing the emergence of numerous companies focused on exosome-based therapies and products. These organisations are involved in the development of proprietary technologies, the establishment of manufacturing competencies, and the advancement of therapeutic candidates through preclinical and clinical stages. Exosome therapeutics offer several advantages over conventional therapeutic approaches. It has the potential to cross the biological barrier and display low immunogenicity, and it can be engineered for targeting particular cells or tissues. Such properties make exosomes an attractive option for drug delivery and regenerative medicine. All these factors are ultimately driving the global Exosome Therapeutics market.

Exosome Therapeutics Market Size

Get an overview of this study by requesting a free sample

Recent Development

  • In August 2021: ExoCoBio invested around USD 20 Million in making the first Clinical Grade Exosome GMP Manufacturing facility in the world. It has two types of advanced exosome production lines in Osong, South Korea. It is helping the organization to invest and research more in the exosome-related market, which eventually drives the Exosome therapeutics market.

Market Dynamics

Drivers

Growing demand for personalized medicine– There are growing cases of chronic diseases like cancer, neurodegenerative conditions and cardiovascular diseases. Cancer has become the leading cause of death in the US. For instance, in 2018, there were an estimated 1,735,350 new diagnoses and around 609,640 cancer-related deaths. Hence, there is a growing focus on personalised medicine, an approach to healthcare that involves tailoring medical treatment to the individual characteristics of each patient. Hence, Exosome therapeutics show promise as they are used for the targeted delivery of therapeutic cargo to specific cells or tissues affected by disease. The primary goal of personalised medicine is to enhance the effectiveness and efficiency of healthcare by providing treatments tailored to the specific needs and characteristics of each patient. All these factors eventually propel the growth of the Exosome Therapeutics market.

Restraints

Complex process – Exosomes can be contaminated, which can be harmful and affect the market. Exosomes, if not extracted properly and sterilised, may contain intracellular and extracellular genetic material, which can be very harmful. This can lead to incorrect signals being sent to cells, which could cause abnormal cell development. It could be fatal. All these factors are acting as restraints for the market.

Opportunities

More investment in R&D – Exosome technology has been developing in recent years, with increased investment in R&D in this sector. This technology is getting integrated into the fields of precision medicine, liquid biopsy and regenerative medicine. This cargo, present in exosomes, can provide prognostic information on several diseases, including renal, cardiovascular, neurodegenerative, cancer, and metabolic diseases, among others. Many researchers investigating exosome biomarkers have discovered, identified, and reported the existence of various biomolecules in the lumen of exosomes. This has led to a significant rise in exosome-related cancer biomarker research, which includes the use of exosomes for identification, monitoring and treatment of a broad range of oncologic conditions. Exosomes are also used for the use of cell-free therapeutics. For instance, if the patient is suffering from disease due to missing or defective protein and microRNA, then exosomes of the patient can be isolated and modified with suitable siRNA or protein and injected back into the patient for treatment. All these factors will increase the demand for Exosome Therapeutics in the forecasting period.

Segment Analysis

Regional segmentation analysis

The regions analysed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the most significant global Exosome Therapeutics market, with a 51.11% market revenue share in 2024.

The North American region leads the Exosome Therapeutics market, primarily due to its large presence of advanced healthcare infrastructure. Also, there is a good health remuneration policy.  Moreover, the US has the most advanced R&D centres in the region. Additionally, the geriatric population in the region is growing, accompanied by a surge in cases of chronic wounds. These factors will ultimately lead to a high demand for Exosome Therapeutics in the region.

North America Region Exosome Therapeutics Market Share in 2024 – 51.11%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Therapy Type Segment Analysis

The therapy type segment is divided into allogenic and autologous. Allogenic segment dominated the market, with a market share of around 53.11% in 2024. This significant share is attributed to the broad use of therapeutics and promising potential in the clinical results.  These Allogeneic therapies utilize exosomes, which are produced from healthy donor cells and can then be mass-produced and stored in stock. This makes it available immediately off the shelf, and hence, there is no need for an individualized therapy generation process.

Application Segment Analysis

The application segment is divided into cancer treatment, cardiovascular diseases, infectious diseases and neurological disorders. The cancer treatment segment dominated the market, with a market share of around 37.65% in 2024. This significant share is due to the increased demand for targeted cancer therapies that utilise exosomes. Additionally, the global burden is increasing, and many leading organisations have increased their investment in the advancement of exosome research. Hence, cancer therapies hold a significant share of the  Exosome Therapeutics Market.

Some of the Key Market Players

  • ExoCoBio
  • Evox Therapeutics
  • Coya Therapeutics
  • Curexsys
  • ILIAS Biologics
  • Rion
  • Cellular Biomedicine Group.
  • SHIFTBIO
  • EV Therapeutics

Report Description

Attribute Description
Market Size Revenue (USD Million)
Market size value in 2024 USD 88.10 Million
Market size value in 2034 USD 2,301.47 Million
CAGR (2025 to 2034) 38.58%
Historical data 2021-2023
Base Year 2024
Forecast 2025-2034
Region The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East and Africa. Furthermore, the regions are further analyzed at the country level.
Segments Therapy Type and Application

Frequently Asked Questions

As per The Brainy Insights, the size of the global Exosome Therapeutics market was valued at USD 88.10 Million in 2024 to USD 2,301.47 Million by 2034.

Global Exosome Therapeutics market is growing at a CAGR of 38.58% during the forecast period 2025-2034.

The market's growth will be influenced by growing demand for personalized medicine.

Request Table of Content

+1

This study forecasts revenue at global, regional, and country levels from 2021 to 2034. The Brainy Insights has segmented the global Exosome Therapeutics market based on below mentioned segments:

Global Exosome Therapeutics Market by Therapy Type:

  • Allogenic
  • Autologous

Global Exosome Therapeutics Market by Application:

  • Cancer Treatment
  • Cardiovascular Diseases
  • Infectious Diseases
  • Neurological Disorders

Global Exosome Therapeutics Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts AboutThe Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date